Sign up to save your podcasts
Or
Share Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.
See omnystudio.com/listener for privacy information.
View all episodes
By Bloomberg
4.6
1616 ratings
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.
See omnystudio.com/listener for privacy information.
More shows like Bloomberg Talks
View all
Exchanges
962 Listeners
Bloomberg Intelligence
400 Listeners
Bloomberg Surveillance
1,164 Listeners
Masters in Business
2,178 Listeners
Odd Lots
1,932 Listeners
Bloomberg Businessweek
423 Listeners
Foundering
968 Listeners
Capital Allocators – Inside the Institutional Investment Industry
794 Listeners
Trillions
192 Listeners
Making Sense
57 Listeners
Value Investing with Legends
212 Listeners
Thoughts on the Market
1,297 Listeners
Here's Why
64 Listeners
Out of Office
30 Listeners
Wall Street Week
64 Listeners
The Memo by Howard Marks
449 Listeners
Listen to the Story
4 Listeners
Into the Metaverse
58 Listeners
Bedrock, USA
233 Listeners
Zero: The Climate Race
229 Listeners
Bloomberg Tech
62 Listeners
Bloomberg Daybreak: US Edition
82 Listeners
The Markets
79 Listeners
Bloomberg News Now
58 Listeners
The Deal with Alex Rodriguez and Jason Kelly
84 Listeners
Money Stuff: The Podcast
394 Listeners
In the City
12 Listeners
Bloomberg Opinion
8 Listeners
The Cable
2 Listeners
IVF Disrupted: The Kindbody Story
72 Listeners